SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-044886
Filing Date
2023-02-22
Accepted
2023-02-22 16:38:43
Documents
4
Effectiveness Date
2023-02-22

Document Format Files

Seq Description Document Type Size
1 S-8 d444413ds8.htm S-8 40408
2 EX-5.1 d444413dex51.htm EX-5.1 5010
3 EX-23.1 d444413dex231.htm EX-23.1 2070
4 EX-FILING FEES d444413dexfilingfees.htm EX-FILING FEES 20284
  Complete submission text file 0001193125-23-044886.txt   68902
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269916 | Film No.: 23653840
SIC: 2834 Pharmaceutical Preparations